BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$69.13 USD
-1.56 (-2.21%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $69.01 -0.12 (-0.17%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $0.79 | -0.95% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.57 per share. This reflects a positive earnings surprise of 68.42%. Look out for BMRN's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of $0.79 per share, reflecting a year-over-year increase of 71.74%.
Earnings History
Price & Consensus
Zacks News for BMRN
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services